Immune consequences of stroke and cerebral palsy in adults

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 113-120

  Rogers, Sandra L ^a   Coe, Christopher L ^b   Karaszewski, Joseph W ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cerebral palsy; Interleukin 2; Natural killer cell; Neuroimmunology; Soluble interleukin 2 receptor; Stroke

Indexed keywords

INTERLEUKIN 2;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; BRAIN INJURY; CELL SUBPOPULATION; CEREBRAL PALSY; CLINICAL ARTICLE; CYTOLYSIS; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; KILLER CELL; MALE; NEUROIMMUNOLOGY; PRIORITY JOURNAL; STROKE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; CEREBRAL PALSY; CEREBROVASCULAR DISORDERS; CYCLIC AMP; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEUROIMMUNOMODULATION; RECEPTORS, INTERLEUKIN-2; STRESS;

EID: 0032476561     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00157-X     Document Type: Article

References (49)

1. Azcue M.P., Zello G.A., Levy L.D., Pencharz P.B. Energy expenditure and body composition in children with spastic quadriplegic cerebral palsy. J. Pediatr. 129:1996;870-876.
2. Benschop R.J., Rodriguez-Feurhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research and future directions. Brain Behav. Immun. 10:1996;77-91.
3. Cruse J.M., Lewis R.E., Bishop G.R., Kliesch W.F., Gaitan E., Britt R. Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. Pathobiology. 61:1993;183-192.
4. Cruse J.M., Keith J.C., Bryant M.L., Lewis R.E. Immune system-neuroendocrine dysregulation in spinal cord injury. Immunol. Res. 15:1996;306-314.
5. Cruse J.M., Lewis R.E., Bishop G.R., Lampton J.A., Mallory M.D., Bryant M.L., Keith J.C. Adhesion molecules and wound healing in spinal cord injury. Pathobiology. 64:1996;193-197.
6. Delrue C., Deleplanque B., Fouge-Pont F., Vitiello S., Neveu P.J. Brain monoaminergic, neuroendocrine, and immune responses to an immune challenge in relation to brain and behavioral lateralization. Brain Behav. Immun. 8:1994;137-152.
7. Denenberg V.H., Sherman G.F., Schrott L.M., Rosen G.D., Galaburda A.M. Spatial learning, discrimination learning, paw preference and neocortical ectopias in two autoimmune strains of mice. Brain Res. 562:1991;98-104.
8. Esterling B.A., Kiecolt-Glaser J.K., Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity. Psychosom. Med. 58:1996;264-272.
9. Franceschi C., Licastro F., Paolucci P., Masi M., Cavicchi S., Zannotti M. T and B lymphocyte sub-populations in Down's syndrome. A study on non-institutionalized subjects. J. Ment. Defic. Res. 22:1978;179-191.
10. Frederick M., Grimm E., Krohn E., Smid C., Yu T.K. Cytokine-induced cytotoxic function expressed by lymphocytes of the innate immune system: distinguishing characteristics of NK and LAK based on functional and molecular markers. J. Interferon Cytokine Res. 17:1997;435-447.
11. Ganguli R., Rabin B.S. Increased serum interleukin-2 receptor concentration in schizophrenic and brain-damaged subjects. Arch. Gen. Psychiatry. 46:1989;292.
12. Glaser R., Kennedy S., Lafuse W.P., Bonneau R.H., Speicher C., Hillhouse J., Kiecolt-Glaser J.K. Psychological stress-induced modulation of interleukin-2 receptor gene expression and interleukin-2 production in peripheral blood leukocytes. Arch. Gen. Psychiatry. 47:1990;707-712.
13. Gooding R., Riches R., Dadian G., Moore J., Gore M. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2. Br. J. Cancer. 72:1995;455-542.
14. Hachinski V. Classification of stroke for clinical trials. Stroke. 21(9 suppl.):1990;1127-1129.
15. Hanisch U.-K., Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21:1996;246-284.
16. Hass W., Pererra P., Tonegawa S. Gamma/delta cells. Ann. Rev. Immunol. 11:1993;637-685.
17. Hasselkus B.R. Barthel self-care index and geriatric home care patients. Phys. Occup. Ther. Geriatr. 1:1982;11-21.
18. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psychiatr. Bull. 113:1993;472-486.
19. Irwin M., Daniels M., Bloom E.T., Smith T.L., Weiner H. Life events, depressive symptoms, and immune function. Am. J. Psychiatry. 144:1987;437-441.
20. Kang D.H., Davidson R.J., Coe C.L., Wheeler R.E., Tomarken A.J., Ershler W.B. Frontal brain asymmetry and immune function. Behav. Neurosci. 105:1991;860-869.
21. Karaszewski J.W., Reder A.T., Anlar B., Arnanson B.G.W. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J. Neuroimmunol. 43:1993;1-8.
22. Kawano Y., Noma T., Yoshizawa I., Maruki K., Yata J. Association of increased numbers of peripheral blood double-negative T-lymphocytes with elevated serum IgG levels in severely handicapped children. Eur. J. Pediatr. 153:1994;884-890.
23. Kliesch W.F., Cruse J.M., Lewis R.E., Bishop G.R., Brackin B., Lampton J. Restoration of depressed immune function in spinal cord injury patients receiving rehabilitation therapy. Paraplegia. 34:1996;82-90.
24. Korpelainen J.T., Sotaniemi K.A., Myllyla V.V. Asymmetrical skin temperature in ischemic stroke. Stroke. 26:1995;1543-1547.
25. Korpelainen J.T., Sotaniemi K.A., Huikuri H.V., Myllya V.V. Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemispheric brain infarction. Stroke. 27:1996;2059-2063.
26. Kostic V., Mostarica-Stojkovic M., Ramic Z., Kovacevic M., Lukic M. Serum immunoinhibitory factors in stroke patients. Eur. Neurol. 28:1988;331-334.
27. Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel Index. Maryland State Med. J. 14:1965;61-65.
28. Malek-Ahmadi P. Neuropsychiatric aspects of cytokines research: an overview. Neurosci. Biobehav. Rev. 20:1996;359-365.
29. Maloney E.M., Morris Brown L., Kuvman C.C., Fuchs D., Nelson D.L., Wachter H., Blattner W.A., Tollerud D.J. Temporal variability in immunological parameters: peripheral blood mononuclear cell subsets, serum immunoglobulins, and soluble markers of immune system activation. J. Clin. Lab. Anal. 11:1997;190-195.
30. McDonald K.C., Valmassy R.L. Cerebral palsy: a literature review. J. Am. Pediatr. 77:1987;471-483.
31. McKinnon W., Weisse C.S., Reynolds C.P., Baum A. Chronic stress, leukocyte sub-populations, and humoral response to latent viruses. Health Psychol. 8:1989;389-402.
32. Multti, M., Sterling, H.M., Spalding, N.V., 1978. Quick Neurological Screening Test (Manual). Academic Therapy Publications, Novato, CA.
33. Naver H., Blomstrand C., Ekholm S., Jensen C., Karlsson T., Wallin G. Autonomic and thermal sensory symptoms and dysfunction after stroke. Stroke. 26:1995;1379-1385.
34. Neveu P.J., Taghzouti K., Dantzer R., Simon H., LeMoal M. Modulation of mitogen-induced lymphoproliferation by cerebral neocortex. Life Sci. 38:1986;1907-1913.
35. Neveu P.J., Delrue C., Deleplanque B., D'Amato F.R., Puglisi-Allegra S., Cabib S. Influence of brain and behavioral lateralization in brain. Ann. New York Acad. Sci. 64:1994;271-282.
36. Ohara Y., Wakiguchi H., Kurashige T. Immunological studies of severe mentally and physically handicapped patients: grade for disturbance in motor function as the most important factor of abnormal immunity. Jpn. J. Pediatr. 93:1989;1507-1512.
37. Pavlidis N., Chirigos M. Stress-induced impairment of macrophage tumoricidal function. Psychosom. Med. 42:1980;47-54.
38. Renoux, G., Biziere, K., 1991. Neocortex lateralization of immune function and of the activities of imuthiol, a T cell-specific immunopotentiator. In: Ader, R., Felton, D., Cohen, N. (Eds.), Psychoneuroimmunology. Academic Press, New York, pp. 127-147.
39. Robinson R.G., Coyle J.T. The differential effect of right- versus left-hemispheric cerebral infarction on catecholamines and behavior in the rat. Brain Res. 188:1980;63-78.
40. Robinson R.G., Shoemaker W.J., Schlumpf M. Time course of changes in catecholamines following right-hemispheric cerebral infarction in the rat. Brain Res. 181:1980;202-208.
41. Robinson R.G., Kubos Z.L., Starr L.B., Rao K., Trice T.R. Mood disorders in stroke patients: importance of location of lesion. Brain. 107:1984;81-93.
42. Robinson R.G., Starr L.B., Lipsey J.R., Rao K., Price T.R. A two-year longitudinal study of post-stroke mood disorders: dynamic changes in associated variables over the first six months of follow-up. Stroke. 15:1994;510-517.
43. Segal J.L., Gonzales E., Yousufi S., Jamshidipour L., Brunnerman S.R. Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Arch. Phys. Med. Rehabil. 78:1997;44-47.
44. Strauman T.J., Lemieux A.M., Coe C.L. Self-discrepancy and natural killer cell activity: immunological consequences of negative self-evaluation. J. Pers. Soc. Psychol. 64:1993;1042-1052.
45. Tarkowski E., Ekelund P., Tarkowski A. Enhancement of antigen-specific T cell reactivity on the affected side in stroke patients. J. Neuroimmunol. 34:1991;61-67.
46. Tarkowski E., Ekelund P., Tarkowski A. Increased systemic T-lymphocyte reactivity in patients with established stroke. J. Clin. Lab. Immunol. 35:1991;171-176.
47. Tarkowski E., Naver H., Wallin B.G., Blomstrand C., Tarkowski A. Lateralization of T-lymphocyte responses in patients with stroke. Effect of sympathetic dysfunction? Stroke. 26:1995;57-62.
48. Tarkowski E., Naver H., Wallin B.G., Blomstrand C., Grimby G., Tarkowski A. Lateralization of cutaneous inflammatory responses in patients with unilateral paresis after poliomyelitis. J. Neuroimmunol. 67:1996;1-6.
49. Yamamoto T., Hara T., Nanba E., Ohashi S., Suzui N., Yoshino K., Takeshita K. Abnormal expansion of peripheral γδ T cells in patients with neurologic disorders. Brain Behav. Immun. 11:1997;157-166.